Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalMarket Capitalization

RedHill Biopharma (RDHL) Return on Equity: 2019

  • RedHill Biopharma's Return on Equity was N/A to 0.20% in Q2 2019 from the same period last year, while for Jun 2019 it was 0.20%, marking a year-over-year change of. This contributed to the annual value of 6.33% for FY2024, which is 736.00% up from last year.
  • According to the latest figures from Q2 2019, RedHill Biopharma's Return on Equity is 0.20%, which was down 28.92% from 0.28% recorded in Q1 2019.
  • Over the past 5 years, RedHill Biopharma's Return on Equity peaked at 0.28% during Q1 2019, and registered a low of 0.20% during Q2 2019.
  • Over the past 1 years, RedHill Biopharma's median Return on Equity value was 0.24% (recorded in 2019), while the average stood at 0.24%.